CBIO · Crescent Biopharma, Inc.
$16.23
-1.09 (-6.29%)
At close · Aug 20
Market Cap
$602.85M
Shares
37.14M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-07-01 | — | $200,000,000 | — | — | 10-Q , filed 2026-07-30 |
Key facts
CIK
1253689
CUSIP
G2545C104
13F (30d)
77 filings
77 filers
Visit website
Investor relations